NSE › Healthcare

Alivus Life Sciences Limited (ALIVUS)

NSE · Healthcare · Drug Manufacturers - Specialty & Generic

₹1,214.40+4.69%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
₹689 cr
Revenue YoY
+14.4%
Net profit
₹163 cr
Profit YoY
+14.7%
EPS
₹13.22
EPS estimate
₹11.70
Net margin
23.6%

EPS came in at 13.22 against a street estimate of 11.70 — a beat of 13.0%.

Key statistics

Market cap
₹14,794 cr
P/E
24.6
Forward P/E
19.6
P/B
4.27
Book value
₹271.02
EPS (TTM)
₹49.07
52-week high
₹1,225.00
52-week low
₹819.00
50-day MA
₹1,099.14
200-day MA
₹985.54
Beta
0.04

Analyst view

with an average price target of ₹1,335.00.

Shareholding

Promoters
76.10%
Institutions
8.79%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Alivus Life Sciences Limited — free to start.

Google PlayApp Store

Other Healthcare companies

Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedCipla LimitedZydus Lifesciences LimitedLupin LimitedMax Healthcare Institute LimitedMankind Pharma LtdLaurus Labs LimitedLenskart Solutions LtdDr. Reddy's Laboratories Limited

Data updated 2026-08-05.